Granahan Investment Management, LLC Paratek Pharmaceuticals, Inc. Transaction History

Granahan Investment Management, LLC

$2.38 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$2.94 - $4.77 $2.2 Million - $3.58 Million	-749,740 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$4.07 - $5.3 $292,689 - $381,144	-71,914 Reduced 8.75%	749,740 $3.37 Million
Q3 2021 Nov 15, 2021	SELL	$4.7 - $7.24 $59,248 - $91,267	-12,606 Reduced 1.51%	821,654 $3.99 Million
Q2 2021 Aug 16, 2021	SELL	$6.81 - $10.93 $158,795 - $254,865	-23,318 Reduced 2.72%	834,260 $5.69 Million
Q1 2021 May 17, 2021	BUY	$6.14 - $8.31 $1.73 Million - $2.34 Million	281,456 Added 48.85%	857,578 $6.06 Million
Q4 2020 Feb 12, 2021	SELL	$4.58 - $7.14 $513,527 - $800,565	-112,124 Reduced 16.29%	576,122 $3.61 Million
Q3 2020 Nov 12, 2020	BUY	$4.19 - $6.69 $21,549 - $34,406	5,143 Added 0.75%	688,246 $3.72 Million
Q2 2020 Aug 14, 2020	SELL	$2.97 - $5.22 $58,298 - $102,463	-19,629 Reduced 2.79%	683,103 $3.57 Million
Q1 2020 May 12, 2020	SELL	$2.67 - $4.97 $24,999 - $46,534	-9,363 Reduced 1.31%	702,732 $2.21 Million
Q4 2019 Feb 14, 2020	BUY	$2.93 - $4.5 $1.57 Million - $2.4 Million	534,222 Added 300.34%	712,095 $2.87 Million
Q3 2019 Nov 15, 2019	BUY	$3.08 - $5.76 $34,991 - $65,439	11,361 Added 6.82%	177,873 $768,000
Q2 2019 Aug 14, 2019	SELL	$3.47 - $6.32 $7,852 - $14,302	-2,263 Reduced 1.34%	166,512 $664,000
Q1 2019 May 14, 2019	SELL	$5.36 - $7.24 $62,899 - $84,961	-11,735 Reduced 6.5%	168,775 $905,000
Q4 2018 Feb 13, 2019	SELL	$4.8 - $11.6 $14,904 - $36,018	-3,105 Reduced 1.69%	180,510 $926,000
Q3 2018 Nov 13, 2018	BUY	$9.05 - $10.95 $64,046 - $77,493	7,077 Added 4.01%	183,615 $1.78 Million
Q2 2018 Aug 15, 2018	BUY	$10.2 - $13.9 $1.8 Million - $2.45 Million	176,538 New	176,538 $1.8 Million

Others Institutions Holding PRTK

# of Institutions

Shares Held

1.54M

Call Options Held

Put Options Held

View Full List

About Paratek Pharmaceuticals, Inc.

Ticker PRTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,862,500
Description
Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectru...

More about PRTK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Granahan Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Granahan Investment Management, LLC with notifications on news.

Account